Here are five observations:
1. The increasing popularity of minimally invasive spine surgery will also spur market growth.
2. The costliness of treatments, unfavorable product approval processes and complicated reimbursements policies will deter market growth.
3. North America and Europe are anticipated to lead the global market, due to an increase in the geriatric population.
4. The Asia Pacific region will see the strongest market growth because of increasing economic affluence.
5. Key global market players include Medtronic, DePuy Synthes, Stryker, Orthofix, NuVasive, Zimmer Biomet, Globus Medical, Alphatec, K2M and LDR.
More articles on spine:
Illicit drug use higher among adults with chronic low back pain: 5 key notes
BlueCross provides $1.3M grant for opioid abuse fight: 7 insights
The Spine & Sports Health Center adds SCS trial procedures to practice — 4 key points
